Zobrazeno 1 - 10
of 726
pro vyhledávání: '"biosafety level"'
Autor:
Shine Varghese Jancy, Santhik Subhasingh Lupitha, Aneesh Chandrasekharan, Shankara Narayanan Varadarajan, Shijulal Nelson-Sathi, Roshny Prasad, Sara Jones, Sreekumar Easwaran, Pramod Darvin, Aswathy Sivasailam, Thankayyan Retnabai Santhoshkumar
Publikováno v:
Biological Procedures Online, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background The entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the host cell is mediated through the binding of the SARS-CoV-2 Spike protein via the receptor binding domain (RBD) to human angiotensin-converting enz
Externí odkaz:
https://doaj.org/article/1349fc4b8aee440e8289ad842f26392f
Autor:
Sadia Shakoor, Imran Ahmed, Khalid Wahab, Samreen Shafiq, Asima Shahid, Shazia Chishti, Hina Ghulam, Rumina Hasan
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 2, Pp 184-191 (2023)
Objectives: We recount our experiences of relocating an active mycobacteriology reference level service in Karachi, Pakistan, from an older accredited biosafety level-3 facility to a newly constructed and environmentally validated facility. Methods:
Externí odkaz:
https://doaj.org/article/ba68ceefd04e4ab2ad700b0487ac8877
Publikováno v:
Pathogens, Vol 13, Iss 2, p 167 (2024)
Single-cell RNA sequencing has soared in popularity in recent years. The ability to deeply profile the states of individual cells during the course of disease or infection has helped to expand our knowledge of coordinated responses. However, signific
Externí odkaz:
https://doaj.org/article/5b877b4717a34e428dcc232105ab2f33
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 4376-4380 (2022)
Research with infectious SARS-CoV-2 is complicated because it must be conducted under biosafety level 3 (BSL-3) conditions. Recently, we constructed a live attenuated SARS-CoV-2 virus by rational design through partial recoding of the SARS-CoV-2 geno
Externí odkaz:
https://doaj.org/article/e02598ba1c2a43c6ab7355566cc42792
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christopher J. LaRocca, Kari L. Jacobsen, Kazuho Inoko, Stanislav O. Zakharkin, Masato Yamamoto, Julia Davydova
Publikováno v:
Viruses, Vol 15, Iss 7, p 1495 (2023)
There have been numerous advances in gene therapy and oncolytic virotherapy in recent years, especially with respect to cutting-edge animal models to test these novel therapeutics. With all of these advances, it is important to understand the biosafe
Externí odkaz:
https://doaj.org/article/f76a5b134f8345fc81f8e1e8a77b38a9
Autor:
Laís D. Coimbra, Alexandre Borin, Marina Fontoura, Humberto D. Gravina, Alice Nagai, Jacqueline Farinha Shimizu, Karina Bispo-dos-Santos, Fabiana Granja, Paulo S. L. Oliveira, Kleber G. Franchini, Kirandeep Samby, Marjorie Bruder, José Luiz Proença-Módena, Daniela B. B. Trivella, Juliana H. C. Smetana, Artur T. Cordeiro, Rafael Elias Marques
Publikováno v:
Frontiers in Virology, Vol 2 (2022)
Until December 2021, the COVID-19 pandemic has caused more than 5.5 million deaths. Vaccines are being deployed worldwide to mitigate severe disease and death, but continued transmission and the emergence of SARS-CoV-2 variants indicate that specific
Externí odkaz:
https://doaj.org/article/a5ef3494e053423bab15254c1229c102
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 11, Pp 2586-2590 (2020)
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to sterilize samples being removed from containment areas. We validated procedures using sterile filtration and meth
Externí odkaz:
https://doaj.org/article/9c1396b5d3484555baebac338abae414
Autor:
Shumpei Watanabe, Shuetsu Fukushi, Toshihiko Harada, Masayuki Shimojima, Tomoki Yoshikawa, Takeshi Kurosu, Yoshihiro Kaku, Shigeru Morikawa, Masayuki Saijo
Publikováno v:
Virology Journal, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe encephalitis and respiratory disease with a high mortality rate in humans. During large outbreaks of the viral disease, serological testing of serum sample
Externí odkaz:
https://doaj.org/article/d0ba60568cf4418dbded396f0776e6d2
Autor:
Marcela Salazar-García, Samyr Acosta-Contreras, Griselda Rodríguez-Martínez, Armando Cruz-Rangel, Alejandro Flores-Alanis, Genaro Patiño-López, Victor M. Luna-Pineda
Publikováno v:
Frontiers in Microbiology, Vol 12 (2022)
World Health Organization (WHO) has prioritized the infectious emerging diseases such as Coronavirus Disease (COVID-19) in terms of research and development of effective tests, vaccines, antivirals, and other treatments. Severe Acute Respiratory Synd
Externí odkaz:
https://doaj.org/article/9f0c5b7980154179a0765a01d6cac58f